C-reactive protein-to-lymphocyte ratio is a reliable marker in patients with COVID-19 infection: the CLEAR COVID study
Muhammed Emin Demirkol, Satılmış Bilgin, Gizem Kahveci, Özge Kurtkulağı, Burcin M. Atak Tel, Tuba Taslamacıoğlu Duman, Gülali Aktaş
Abstract
C-reactive protein-to-lymphocyte ratio is a reliable marker in patients with COVID-19 infection: the CLEAR COVID study La relación proteína C-reactiva-a-linfocito es un marcador confiable en pacientes con infección
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyLymphocyteMedicineImmunologyPathologyInfectious disease (medical specialty)DiseaseOutbreakCOVID-19 Clinical Research StudiesPancreatitis Pathology and TreatmentInflammatory Biomarkers in Disease Prognosis